Kiin Bio
Kiin Bio39
Kiin Bio
About
What does Kiin Bio do?
Kiin Bio is a London-based AI drug discovery company building Virtual Scientists to accelerate pharmaceutical research. Its platform deploys generative AI agents that plan, analyze, and orchestrate experiments across lab data, modeling tools, and analysis pipelines, helping researchers navigate drug discovery at scale.
What is Kiin Bio's revenue?
StartupHub estimates Kiin Bio's annual revenue at $1.1M (range $365K to $2.2M, 33% confidence), based on comparable companies in the sector.
What is Kiin Bio's valuation?
StartupHub estimates Kiin Bio's effective valuation at $15.5M (range $10.3M to $24.6M, 21% confidence), based on comparable companies in the sector.
How much funding has Kiin Bio raised?
Kiin Bio has raised a total of $4M in funding. The most recent round on record is Pre-Seed.
What industry does Kiin Bio operate in?
Kiin Bio operates in Artificial Intelligence, Biotechnology, Drug Discovery, Life Sciences.
Where is Kiin Bio headquartered?
Kiin Bio is headquartered in United Kingdom.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.